GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Autodesk, Inc. (ADSK) [hlAlert]

Rating:
Buy ADSK
up 78.25 %

Autodesk, Inc. (ADSK) upgraded to Buy with price target $31 by Needham

Posted on: Wednesday,  Feb 24, 2010  8:25 AM ET by Needham

Needham rated Buy Autodesk, Inc. (NASDAQ: ADSK) on 02/24/2010, when the stock price was $28.05. Since
then, Autodesk, Inc. has gained 78.25% as of 11/20/2015's recent price of $50.00.
If you would have followed this Needham's recommendation on ADSK, you would have gained 78.25% of your investment in 2095 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/24/2010 8:25 AM Buy
None
28.05 31.00
as of 12/31/2010
1 Week up  5.57 %
1 Month up  17.59 %
3 Months up  29.80 %
1 YTD up  47.95 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/21/2008 9:25 AM Hold
None
12.84
11/18/2008 9:25 AM Buy
None
18.96 27.00
8/15/2008 9:25 AM Buy
None
37.96 45.00
2/27/2008 9:25 AM Hold
None
33.85
8/17/2007 9:25 AM Buy
None
44.98 55.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy